Invasive Haemophilus influenzae Type b Disease in England and Wales: Who Is at Risk After 2 Decades of Routine Childhood Vaccination?
Author(s) -
Sarah Collins,
Mary Ramsay,
Helen Campbell,
Mary Slack,
Shamez Ladhani
Publication year - 2013
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/cit579
Subject(s) - medicine , vaccination , pediatrics , incidence (geometry) , case fatality rate , epidemiology , hib vaccine , disease , conjugate vaccine , epiglottitis , haemophilus influenzae , pneumonia , public health , meningitis , immunization , immunology , antibiotics , pathology , physics , microbiology and biotechnology , antigen , optics , biology
The introduction of the Haemophilus influenzae serotype b (Hib) conjugate vaccine into national immunization has led to rapid and sustained declines in invasive Hib disease incidence across all age groups. In industrialized countries with established Hib vaccination programs, however, little is known about individuals who develop invasive Hib disease. This study describes the epidemiology of invasive Hib disease in England and Wales during 2000-2012 and the clinical characteristics of laboratory-confirmed Hib cases diagnosed during 2009-2012.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom